<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:chebi fb="0" ids="25029">Leukotriene</z:chebi> (LT) B(4) is a <z:chebi fb="23" ids="18059">lipid</z:chebi> inflammatory mediator implicated in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in animal models of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagitis</z:e>, but little is known about the <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi>-<z:chebi fb="0" ids="25029">leukotrienes</z:chebi> (LTC(4), LTD(4), LTE(4)), which have distinct inflammatory and tumorigenic actions in other tissues </plain></SENT>
<SENT sid="1" pm="."><plain>We recently showed that the terminal enzymes for the synthesis of both LT families are highly expressed in human oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e>) tissues </plain></SENT>
<SENT sid="2" pm="."><plain>This study therefore examined the capacity of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (BM) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> tissues to synthesise LTs in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS AND METHODS: Oesophageal biopsies from patients with BM (n = 14), high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 2), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> (n = 11), and squamous control tissues (n = 11) were cultured with <z:chebi fb="0" ids="22986">calcium ionophore</z:chebi> A32187 (2 μM) for 60 min </plain></SENT>
<SENT sid="4" pm="."><plain>LTB(4) and <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi>-<z:chebi fb="0" ids="25029">leukotrienes</z:chebi> were extracted and measured by specific enzyme immunoassays </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Levels of LTB(4) and <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi>-<z:chebi fb="0" ids="25029">leukotrienes</z:chebi> were 8.6-fold (P &lt; 0.01) and 2.4-fold (P &lt; 0.02) higher, respectively, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> tissues than in squamous control tissues, but levels in BM tissues (n = 14) were not altered </plain></SENT>
<SENT sid="6" pm="."><plain>Production of the two LT families correlated across <z:hpo ids='HP_0000001'>all</z:hpo> tissue types (r = 0.62, p &lt; 0.00005) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Increased synthesis of LTB(4) and <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi>-<z:chebi fb="0" ids="25029">leukotrienes</z:chebi> has not previously been shown in human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OA</z:e> tissue and our results may indicate a role of these <z:chebi fb="23" ids="18059">lipids</z:chebi> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's disease</z:e> progression </plain></SENT>
</text></document>